These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37479091)

  • 21. Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling.
    Liu Y; Wang S; Kan J; Zhang J; Zhou L; Huang Y; Zhang Y
    Curr Neuropharmacol; 2020; 18(4):260-276. PubMed ID: 31686629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Long and Winding Road to Gamma-Amino-Butyric Acid as Neurotransmitter.
    Avoli M; Krnjević K
    Can J Neurol Sci; 2016 Mar; 43(2):219-26. PubMed ID: 26763167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoamine neurotransmitter disorders--clinical advances and future perspectives.
    Ng J; Papandreou A; Heales SJ; Kurian MA
    Nat Rev Neurol; 2015 Oct; 11(10):567-84. PubMed ID: 26392380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder.
    Ruzicka WB; Subburaju S; Benes FM
    JAMA Psychiatry; 2015 Jun; 72(6):541-51. PubMed ID: 25738424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.
    Devor A; Andreassen OA; Wang Y; Mäki-Marttunen T; Smeland OB; Fan CC; Schork AJ; Holland D; Thompson WK; Witoelar A; Chen CH; Desikan RS; McEvoy LK; Djurovic S; Greengard P; Svenningsson P; Einevoll GT; Dale AM
    Mol Psychiatry; 2017 Jun; 22(6):792-801. PubMed ID: 28348379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic dysregulation of protocadherins in human disease.
    El Hajj N; Dittrich M; Haaf T
    Semin Cell Dev Biol; 2017 Sep; 69():172-182. PubMed ID: 28694114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional implications of neurotransmitter co-release: glutamate and GABA share the load.
    Seal RP; Edwards RH
    Curr Opin Pharmacol; 2006 Feb; 6(1):114-9. PubMed ID: 16359920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulations of Synaptic Vesicle Trafficking in Schizophrenia.
    Egbujo CN; Sinclair D; Hahn CG
    Curr Psychiatry Rep; 2016 Aug; 18(8):77. PubMed ID: 27371030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocytosis of GABA receptor: Signaling in nervous system.
    Sharma P; Sharma BS; Raval H; Singh V
    Prog Mol Biol Transl Sci; 2023; 196():125-139. PubMed ID: 36813355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARγ Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain Neurons.
    Wnuk A; Rzemieniec J; Staroń J; Litwa E; Lasoń W; Bojarski A; Kajta M
    Mol Neurobiol; 2019 Jul; 56(7):4820-4837. PubMed ID: 30402708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptomic responses in mouse brain exposed to chronic excess of the neurotransmitter glutamate.
    Wang X; Bao X; Pal R; Agbas A; Michaelis EK
    BMC Genomics; 2010 Jun; 11():360. PubMed ID: 20529287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic mechanisms of gene expression regulation in neurological diseases.
    Gos M
    Acta Neurobiol Exp (Wars); 2013; 73(1):19-37. PubMed ID: 23595281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The interaction between gamma-aminobutyric acid and other related neurotransmitters in depression].
    Li Z; An SC; Li JN
    Sheng Li Ke Xue Jin Zhan; 2014 Jun; 45(3):190-4. PubMed ID: 25219270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells.
    Watanabe M; Maemura K; Oki K; Shiraishi N; Shibayama Y; Katsu K
    Histol Histopathol; 2006 Oct; 21(10):1135-41. PubMed ID: 16835836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.
    Winter C; Djodari-Irani A; Sohr R; Morgenstern R; Feldon J; Juckel G; Meyer U
    Int J Neuropsychopharmacol; 2009 May; 12(4):513-24. PubMed ID: 18752727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients.
    Bullock WM; Cardon K; Bustillo J; Roberts RC; Perrone-Bizzozero NI
    Am J Psychiatry; 2008 Dec; 165(12):1594-603. PubMed ID: 18923069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.
    Grados MA; Atkins EB; Kovacikova GI; McVicar E
    Psychol Res Behav Manag; 2015; 8():115-31. PubMed ID: 25995654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.
    Bermingham DP; Hardaway JA; Refai O; Marks CR; Snider SL; Sturgeon SM; Spencer WC; Colbran RJ; Miller DM; Blakely RD
    J Neurosci; 2017 Sep; 37(38):9288-9304. PubMed ID: 28842414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders.
    Ng J; Heales SJ; Kurian MA
    Paediatr Drugs; 2014 Aug; 16(4):275-91. PubMed ID: 25011953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics.
    Yadav D; Kumar P
    Neurochem Int; 2022 Jun; 156():105327. PubMed ID: 35331828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.